Redbubble: Not yet through the trouble, but backing the bubble
About the author:
- Author name:
- By Anthony Porto
- Job title:
- Former Senior Analyst
- Date posted:
- 20 August 2021, 8:00 AM
- Sectors Covered:
- Online, Emerging Tech
- Redbubble's (ASX:RBL) FY21 result came in slightly below forecasts (-0.8% Marketplace rev, -1% GP and -2% EBITDA). Given quarterly reporting, the quantum of the miss in the 4Q was a degree higher (-5% at MP Rev and GP lines, -40% EBITDA on small no.)
- The magnitude of near term downgrades we have put through our forecasts, the 39% intraday movement in the stock, and a likely near term retreat as short covering abides, has still not dissuaded us from moving to an Add rating.
- Whilst the worse may be yet to come, we are taking a longer term view, being believers in the earnings and growth potential of the RBL platform. Our DCF derived valuation reduces 11% to (login to view).
- We remove the 10% discount previously applied based on near-term earnings uncertainty (with this hopefully having played out) with our target price down only 1% on previous.
Q4 shows difficulty in comping COVID tailwinds, but also some resiliency
RBL’s FY21 result of MP Rev $553m (+58% on pcp, +70% in constant currency) GP $223m (+66%, +79% CC) and EBITDA of $52.7m (+605% on pcp) showed the benefit of COVID tailwinds (both to e-comm in general and mask sales specifically).
The severe deceleration seen in Q4 (-6% MP rev on pcp, -8% GP and -76% EBITDA) shows the perils of cycling these tailwinds and an artificially depressed cost base (both opex and marketing spend).
Despite this, the Q4 result excluding mask sales (a hopefully no truer one-off benefit) of MP rev +0.7% (+6% CC terms) was actually a commendable performance (25% 2yr CAGR).
RBL has hinted at capital management initiatives ($99m cash, $56m ex WC). With dividends being ruled out, a buyback or acquisition are the obvious choices.
Some slight inklings of improving loyalty but long way to go with PAC efficiency continuing to decline
Repeat purchasers @ 42% of MP rev (in line with FY20) was commendable in the context of 40% customer growth (to 9.5m). Repeat purchase growth of 67%, outstripping first purchase (+52% on pcp) and the oft quoted 1.1 transactions per customer lifting to ~1.19x (past 18mths) provide some evidence of increased loyalty.
RBL remains heavily focused on this (read investment).
The above becomes increasingly important with the brief hiatus to RBL’s lower PAC efficiency trend (PAC ROI) continuing it’s downward trajectory (refer body of note).
ST brings eyewatering downgrades, LT we remain well below RBL’s upwardly revised targets
The leverage in RBL’s business model (that served it well on the upside) has conspired to see large downgrades to our near term forecasts. We show our forecast changes in more detail overleaf, but for FY22, a 10% topline reduction has seen a 30% EBITDA reduction (with 2% increase in opex on prior).
RBL has reaffirmed aspirational CY24+ targets of $1.25b MP Rev, upgrading LT margin expectations (now 13-18% vs 10-15% prev). Our forecasts sit well below these targets, with attainment of the midpoint implying an EBITDA profile 3.7x FY21 (6.8x FY22F) and RBL trading on 4.8x Adj EV/EBITDA (albeit in CY24+).
Back to an Add rating
Despite acknowledging moving back to an Add rating whilst delivering some large near term earnings downgrades may appear incongruous, we believe with expectations rebased, and being closer to exiting the period of maximum comping risk, RBL is now in a position to begin rebuilding momentum.
We remain believers in the LT growth profile of RBL, not to the extent management’s targets would imply, but enough given the rebasing in the stock (- 50% from Jan highs and -14% from when we put the stock on a Hold).
1Q22 earnings update (generally mid Oct) although we anticipate this to represent peak cycling risk.
Ability to show increased customer loyalty and payback of expected increased spend on loyalty initiatives.
Near term earnings risk remains with a declining topline and increased cost investment, increased competitive intensity, marketing cost inflation, general macro risk to discretionary retail, litigation risk (eg Brandy Melville case).
Find out more
Download full research note
You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.
If you would like access or more information, please contact your adviser or nearest Morgans office.
Request a call
Find local branch
Need access to our research?
You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team.
Create trial account
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.